VRNA logo

Verona Pharma (VRNA) Selling, General & Administrative Expenses

Annual SGA

$149.75 M
+$99.40 M+197.40%

December 31, 2024

Summary

Performance

1-Year Change

+197.4%

3-Year Change

+341.65%

5-Year Change

+1399.6%

15-Year Change

+1749.61%

VRNA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.16%
VRNA annual SGA is higher than 77.16% of companies in Healthcare sector

High & Low

All-time High

$149.75 M
VRNA annual SGA is currently at an all-time high

3-Year Low

$26.58 M
VRNA annual SGA is currently +463.41% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
VRNA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
VRNA next annual earnings announcement has not yet been scheduled

OtherVRNAexpensesmetrics:

Annual Total Expenses

$193.31 M
VRNA annual total expenses is $193.31 million

Annual Operating Expenses

$190.72 M
VRNA annual total operating expenses is $190.72 million

Annual Cost Of Goods Sold

$2.58 M
VRNA annual cost of goods sold is $2.58 million

Annual Interest Expense

$23.54 M
VRNA annual interest expense is $23.54 million

Quarterly SGA

$45.09 M
+$9.89 M+28.10%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+201.13%

3-Year Change

+201.13%

5-Year Change

+201.13%

VRNA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.78%
VRNA quarterly SGA is higher than 78.78% of companies in Healthcare sector

High & Low

All-time High

$49.03 M
VRNA quarterly SGA is currently -8.06% below its historical high of $49.03 million

3-Year Low

$5.29 M
VRNA quarterly SGA is currently +752.27% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
VRNA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
VRNA next earnings announcement is scheduled for May 9, 2025

OtherVRNAexpensesmetrics:

Quarterly Total Expenses

$54.44 M
VRNA quarterly total expenses is $54.44 million

Quarterly Operating Expenses

$52.40 M
VRNA quarterly total operating expenses is $52.40 million

Quarterly Cost Of Goods Sold

$2.04 M
VRNA quarterly cost of goods sold is $2.04 million

Quarterly Interest Expense

$10.32 M
VRNA quarterly interest expense is $10.32 million

TTM SGA

-$1.99 B
-$173.97 M-9.58%

December 31, 2024

Summary

Performance

3-Month Change

-1429.27%

1-Year Change

-4053.27%

3-Year Change

-4053.27%

5-Year Change

-4053.27%

VRNA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.59%
VRNA TTM SGA is higher than 24.59% of companies in Healthcare sector

High & Low

All-time High

$10.70 K
VRNA TTM SGA is currently <-9900.00% below its historical high of $10.70 thousand

3-Year Low

-$1.99 B
VRNA TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
VRNA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
VRNA next earnings announcement is scheduled for May 9, 2025

OtherVRNAexpensesmetrics:

Annual Total Expenses

$193.31 M
VRNA annual total expenses is $193.31 million

Annual Operating Expenses

$190.72 M
VRNA annual total operating expenses is $190.72 million

TTM Cost Of Goods Sold

$2.58 M
VRNA TTM cost of goods sold is $2.58 million

TTM Interest Expense

$23.54 M
VRNA TTM interest expense is $23.54 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$149.75 M
VRNA annual SGA is $149.75 million

Annual Operating Expenses

$190.72 M
VRNA annual total operating expenses is $190.72 million

Annual Cost Of Goods Sold

$2.58 M
VRNA annual cost of goods sold is $2.58 million

VRNA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+197.4%+201.1%-4053.3%
3 y3 years+341.6%+201.1%-4053.3%
5 y5 years+1399.6%+201.1%-4053.3%

VRNA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+463.4%-8.1%+752.3%-102.4%at low
5 y5-yearat high+1399.6%-8.1%+1750.0%-332.8%at low
alltimeall timeat high>+9999.0%-8.1%+9537.7%<-9999.0%at low

Verona Pharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$149.75 M(+197.4%)
$45.09 M(+28.1%)
$149.75 M(+25.2%)
Sep 2024
-
$35.20 M(-28.2%)
$119.64 M(+22.3%)
Jun 2024
-
$49.03 M(+140.0%)
$97.79 M(+59.8%)
Mar 2024
-
$20.43 M(+36.5%)
$61.20 M(+21.5%)
Dec 2023
$50.35 M(+89.4%)
$14.97 M(+12.1%)
$50.35 M(+15.2%)
Sep 2023
-
$13.35 M(+7.3%)
$43.70 M(+22.6%)
Jun 2023
-
$12.44 M(+29.7%)
$35.64 M(+24.1%)
Mar 2023
-
$9.59 M(+15.2%)
$28.73 M(+8.1%)
Dec 2022
$26.58 M(-21.6%)
$8.32 M(+57.3%)
$26.58 M(+10.7%)
Sep 2022
-
$5.29 M(-4.3%)
$24.01 M(-18.9%)
Jun 2022
-
$5.53 M(-25.7%)
$29.61 M(-7.7%)
Mar 2022
-
$7.44 M(+29.2%)
$32.06 M(-5.4%)
Dec 2021
$33.91 M(+13.9%)
$5.76 M(-47.1%)
$33.91 M(-14.4%)
Sep 2021
-
$10.88 M(+36.3%)
$39.60 M(+7.0%)
Jun 2021
-
$7.99 M(-14.0%)
$37.01 M(+15.0%)
Mar 2021
-
$9.28 M(-19.0%)
$32.19 M(+8.1%)
Dec 2020
$29.77 M(+198.1%)
$11.45 M(+38.3%)
$29.77 M(+43.4%)
Sep 2020
-
$8.28 M(+161.2%)
$20.75 M(+39.3%)
Jun 2020
-
$3.17 M(-53.8%)
$14.89 M(+3.3%)
Mar 2020
-
$6.86 M(+181.6%)
$14.42 M(+45.0%)
DateAnnualQuarterlyTTM
Dec 2019
$9.99 M(+25.1%)
$2.44 M(+0.5%)
$9.95 M(+5.4%)
Sep 2019
-
$2.42 M(-10.2%)
$9.44 M(+6.5%)
Jun 2019
-
$2.70 M(+13.0%)
$8.86 M(+4.5%)
Mar 2019
-
$2.39 M(+23.7%)
$8.48 M(+4.2%)
Dec 2018
$7.99 M(-1.4%)
$1.93 M(+4.6%)
$8.14 M(+7.8%)
Sep 2018
-
$1.85 M(-20.3%)
$7.55 M(-10.5%)
Jun 2018
-
$2.32 M(+13.4%)
$8.44 M(-2.8%)
Mar 2018
-
$2.04 M(+52.2%)
$8.68 M(+9.5%)
Dec 2017
$8.10 M(+179.8%)
$1.34 M(-50.9%)
$7.93 M(+4.1%)
Sep 2017
-
$2.73 M(+6.7%)
$7.62 M(+29.9%)
Jun 2017
-
$2.56 M(+99.0%)
$5.86 M(+55.6%)
Mar 2017
-
$1.29 M(+24.5%)
$3.77 M(+51.9%)
Dec 2016
$2.89 M(+16.6%)
$1.03 M(+5.5%)
$2.48 M(+71.4%)
Sep 2016
-
$979.70 K(+109.4%)
$1.45 M(+209.4%)
Jun 2016
-
$467.80 K
$467.80 K
Dec 2015
$2.48 M(+39.0%)
-
-
Dec 2014
$1.79 M(-6.7%)
-
-
Dec 2013
$1.91 M(+30.1%)
-
-
Dec 2012
$1.47 M(+4.8%)
-
-
Dec 2011
$1.40 M
-
-

FAQ

  • What is Verona Pharma annual SGA?
  • What is the all time high annual SGA for Verona Pharma?
  • What is Verona Pharma annual SGA year-on-year change?
  • What is Verona Pharma quarterly SGA?
  • What is the all time high quarterly SGA for Verona Pharma?
  • What is Verona Pharma quarterly SGA year-on-year change?
  • What is Verona Pharma TTM SGA?
  • What is the all time high TTM SGA for Verona Pharma?
  • What is Verona Pharma TTM SGA year-on-year change?

What is Verona Pharma annual SGA?

The current annual SGA of VRNA is $149.75 M

What is the all time high annual SGA for Verona Pharma?

Verona Pharma all-time high annual SGA is $149.75 M

What is Verona Pharma annual SGA year-on-year change?

Over the past year, VRNA annual SGA has changed by +$99.40 M (+197.40%)

What is Verona Pharma quarterly SGA?

The current quarterly SGA of VRNA is $45.09 M

What is the all time high quarterly SGA for Verona Pharma?

Verona Pharma all-time high quarterly SGA is $49.03 M

What is Verona Pharma quarterly SGA year-on-year change?

Over the past year, VRNA quarterly SGA has changed by +$30.11 M (+201.13%)

What is Verona Pharma TTM SGA?

The current TTM SGA of VRNA is -$1.99 B

What is the all time high TTM SGA for Verona Pharma?

Verona Pharma all-time high TTM SGA is $10.70 K

What is Verona Pharma TTM SGA year-on-year change?

Over the past year, VRNA TTM SGA has changed by -$2.04 B (-4053.27%)